Treatment practice and outcomes in

Autor: Chong C, Chua, Andrew, Grigg, Jasmine, Singh, Mark P, Droogleever, Lan, Zhang, Andrew, Lim, Chun Y, Fong, Stephen B, Ting, Anthony, Schwarer, Ing S, Tiong, Andrew H, Wei
Rok vydání: 2019
Předmět:
Zdroj: Leukemialymphoma. 61(4)
ISSN: 1029-2403
Popis: Recent regulatory approval of midostaurin, a FLT3 targeting small molecular inhibitor, will likely lead to increased use of midostaurin in combination with intensive chemotherapy for patients with
Databáze: OpenAIRE